Increased Risk of Q151M and K65R Mutations in Patients Failing Stavudine-Containing First-Line Antiretroviral Therapy in Cambodia

• Janin Nouhin ,

  * E-mail: njanin@pasteur-kh.org

  Affiliations HIV/Hepatitis Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia, Université Paris Diderot, Sorbonne Paris Cité, Paris, France

  ⨯
• Yoann Madec,

  Affiliation Emerging Disease Epidemiology Unit, Department of Infection and Epidemiology, Institut Pasteur, Paris, France

  ⨯
• Nicole Ngo-Giang-Huong,

  Affiliations Institut de Recherche pour le Développement (IRD UMI 174), Paris, France, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Laurent Ferradini,

  Affiliation FHI 360, Phnom Penh, Cambodia

  ⨯
• Eric Nerrienet

  Affiliations HIV/Hepatitis Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia, Regulation of Retroviral Infection Unit, Department of Virology, Institut Pasteur, Paris, France

  ⨯